European Heart Journal-Quality of Care and Clinical Outcomes

Article	Citations
Call for emergency action to limit global temperature increases, restore biodiversity, and protect health	96
Ambulance drive-thru troponin, ready to go?	48
Association between the magnitude of periprocedural myocardial injury and prognosis in patients undergoing elective percutaneous coronary intervention	43
Radial first for STEMI and cardiogenic shock: Jumping in the water with your wrists tied	40
Letter to the editor in response to Kobo et al. 2022	35
Long-term aspirin adherence following myocardial infarction and risk of cardiovascular events	34
Implementing rapid algorithms for high-sensitivity troponin—economic benefits and caveat emptor	34
Hypertrophic cardiomyopathy management: a systematic review of the clinical practice guidelines and recommendations	32
Key priorities for the implementation of the 2023 ESC Guidelines for the management of cardiomyopathies in low-resource settings	30
Alcoholic cardiomyopathy-attributed mortality in Europe, 2012–20	29
Secundum atrial septal defect closure in adults in the UK	29
Predictive value of post-percutaneous coronary intervention fractional flow reserve: a systematic review and meta-analysis	27
Myocarditis and pericarditis in adolescents after first and second doses of mRNA COVID-19 vaccines	26
Impact of residual angina on long-term clinical outcomes after percutaneous coronary intervention or coronary artery bypass graft for complex coronary artery disease	26
The cost-effectiveness of semaglutide in reducing cardiovascular risk among people with overweight and obesity and existing cardiovascular disease, but without diabetes	25
Key priorities for the implementation of the 2023 ESC Guidelines for the management of acute coronary syndromes in low-resource settings	24
Quality of life and the assessment of surgical quality	23
Economic burden of cardiovascular disease in the United Kingdom	23
Applicability of guideline-informing lipid-lowering clinical trials to contemporary real-world patients with atherosclerotic cardiovascular disease	23
Influence of multiple risk factor control level on cardiovascular outcomes in hypertensive patients	22
Fifteen-year secular changes in the care and outcomes of patients with out-of-hospital cardiac arrest in Japan: a nationwide, population-based study	22
Correction to: Trends in risk factors among young patients with acute myocardial infarction: a nationwide cohort study	21
Cost-effectiveness of population screening for aortic stenosis	19
Mapping the modern heart failure epidemic: growing burden, root causes, and widening inequalities	19
Sodium-glucose cotransporter 2 inhibitors in patients with heart failure: a systematic review and meta-analysis of randomized trials	18

Standardized and hierarchically classified heart failure and complementary disease monitoring outcome measures: European Unified Registries for Heart Care Evaluation and Randomised Trials (EuroHeart)	18
Impact of low physical activity on cardiovascular disease across regions and demographic groups: insights from the Global Burden of Disease Study	17
Risk-standardized mortality metric to monitor hospital performance for chest pain presentations	17
Erratum to: Economic burden of patients living with heart disease in the last years of life in Australia: a retrospective analysis using linked data	17
Letter to the editor in response to Sengupta et al. (2022)	17
Machine learning for prediction of all-cause mortality after transcatheter aortic valve implantation	17
Cohort profile: Evaluation of the Methods and Management of Acute Coronary Events (EMMACE) longitudinal cohort	16
Cancer and the risk of perioperative arterial ischaemic events	15
Estimated annual healthcare costs after acute pulmonary embolism: results from a prospective multicentre cohort study	15
The beginning of wisdom is the definition of terms: counting heart failure hospitalizations	15
Greenness exposure and mortality risk in a cardio-oncologic population	15
Association of cumulative health status with subsequent mortality in patients with acute heart failure	14
Heart failure with preserved ejection fraction management: a systematic review of clinical practice guidelines and recommendations	14
Cost-Effectiveness of Atrial Fibrillation Screening Programmes Across European Nations	14
Rapid Assessment and Treatment In Decompensated Aortic Stenosis (ASTRID-AS study)- A pilot study	14
Predictive and prognostic value of different cardiac troponin assays: a nationwide register-based cohort study	13
Clinical Outcomes in Hospitalized Patients with Cancer and New versus Preexistent Atrial Fibrillation	13
Comparative efficacy and safety of different catheter ablation strategies for persistent atrial fibrillation: a network meta-analysis of randomized clinical trials	13
Contemporary trends in incident ischaemic stroke, intracranial haemorrhage, and mortality in individuals with atrial fibrillation	13
Post-discharge pharmacotherapy in people with atrial fibrillation hospitalized for acute myocardial infarction: an Australian cohort study 2018–22	13
The effect of mental health conditions on the use of oral anticoagulation therapy in patients with atrial fibrillation: the FinACAF study	13
Prognostic impact of anaemia in patients undergoing aortic valve replacement: a nationwide study	13
Cohort profile: the ESC EURObservational Research Programme Non-ST-segment elevation myocardial infraction (NSTEMI) Registry	12
A decade of follow-up: atrial fibrillation, pulmonary pressure, and the progression of tricuspid regurgitation	12
Periprocedural myocardial infarction after coronary artery bypass grafting: defining what matters	12
Transcatheter vs. surgical mitral valve interventions in patients with prior coronary artery bypass grafting	11
Hospital admissions in the last year of life of patients with heart failure	11
Quality of life and societal costs in patients with dilated cardiomyopathy	11
National health expenditure per capita is associated with CRT implantation practice: findings from the ESC CRT Survey II with 11 088 patients	11
The semaglutide paradox in non-overweight diabetes: a benefit without explanation	11
Association between Early Oral β-Blocker Therapy and Risk for In-Hospital Major Bleeding after Percutaneous Coronary Intervention for Acute Coronary Syndrome: Findings from CCC-ACS Project	11
Suspected Non-ST-elevation acute coronary syndrome meeting rapid rule-out criteria: resource utilization, diagnostic yield, and clinical outcomes of hospital admission	11
Patterns of comorbidities, clinical course, and impact of the ABC Pathway for Integrated Care in patients with atrial fibrillation: a report from the prospective Optimal Thromboprophylaxis in Elderly	11
Safety of AF ablation–its evolution over time and lessons from down under	11
Treating the Patient, Not Just the Valve: Can We Predict Which TAVI Patients Truly Benefit?	11
Trends and projections of heart failure among adolescents and young adults: an in-depth analysis for the Global Burden of Disease Study 2021	10
Tricuspid regurgitation management: a systematic review of clinical practice guidelines and recommendations	10
Global, regional, and national burden of atrial fibrillation/flutter related to metabolic risks over three decades: estimates from the global burden of disease study 2019	10
Predicted clinical and economic burden associated with reduction in access to acute coronary interventional care during the COVID-19 lockdown in two European countries	10
Corrigendum to: Sodium-glucose cotransporter 2 inhibitors in patients with heart failure: a systematic review and meta-analysis of randomized trials	10
Association of baseline and changes in health-related quality of life with mortality following myocardial infarction: multicentre longitudinal linked cohort study	10
Current epidemiology and management of acute heart failure: the multicenter prospective OFICA2 cohort	10
Bacteraemia and infective endocarditis following left-sided heart valve surgery	10
Ischemic Cerebrovascular Events Post Atrial Fibrillation Catheter Ablation: A Descriptive Report on the ITHACA Database	10
Impact of COVID-19 pandemic on the incidence and prevalence of postural orthostatic tachycardia syndrome	10
Has the first year of the COVID-19 pandemic reversed the trends in CV mortality between 1999 and 2019 in the United States?	10
Diagnostic accuracy, clinical characteristics, and prognostic differences of patients with acute myocarditis according to inclusion criteria	9
Reperfusion strategies on the clinical outcomes of ST-elevation myocardial infarction patients over 80 years old in China	9
Implantable cardioverter defibrillators in heart failure with reduced ejection fraction after myocardial infarction: the need for contemporary evidence	9
Elementary school performance of children with congenital heart disease: a Danish nationwide cohort study	9

Quality of care and long-term survival after ST-elevation myocardial infarction in adults with cancer	9
Non-invasive physiological assessment of intermediate coronary stenoses from plain angiography through artificial intelligence: the STARFLOW system	9
Optimizing anticoagulant therapy: is pharmacist-led intervention the best	9
Current management of transition and multidisciplinary care of patients with inherited and rare cardiomyopathies in Europe: results of the European Reference Network for rare and low prevalence comple	9
Incidence, predictors, and prognostic impact of rehospitalization after transcatheter aortic valve implantation	9
Cohort profile: the prospective cohort study on the incidence of metabolic diseases and risk factors in Shunde, China (Speed-Shunde cohort)	8
Heart failure in an ageing world: closing the evidence-equity gap	8
Transcatheter aortic valve replacement in mixed aortic valve disease: a systematic review and meta-analysis	8
Temporal trends in loss of expected lifetime associated with cardiovascular complications following newly diagnosed atrial fibrillation: a Danish nationwide cohort study from 2000 to 2022	8
Comparison of HAS-BLED and ORBIT bleeding risk scores in atrial fibrillation patients treated with non-vitamin K antagonist oral anticoagulants: a report from the ESC-EHRA EORP-AF General Long-Term Re	8
Trends and risk factors analysis of aortic aneurysm mortality in China over thirty years: based on the global burden of disease 2019 data	8
Discharge after primary percutaneous coronary intervention: the earlier the better?	8
Seasonal influenza vaccine uptake among patients with cardiovascular disease in Denmark, 2017–2019	8
Trends in atrial fibrillation-related mortality in Europe, 2008–2019	8
Predictive factors of surgical repair technique in infants with coarctation of the aorta	8
Disparities in ST-elevation myocardial infarction diagnosis and management among patients with mental health conditions	8
Renin–angiotensin system inhibition and in-hospital mortality in acute coronary syndrome patients with advanced renal dysfunction: findings from CCC-ACS project and a nationwide electronic health reco	8
Which frailty tool best predicts morbidity and mortality in ambulatory patients with heart failure? A prospective study	7
Rigour of development of European Society of Cardiology, American College of Cardiology and American Heart Association guidelines over a 12-year period (2013–2024): a systematic review of guidelines	7
Regional disparities in heart transplant mortality in the USA	7
Left ventricular thrombus in ischaemic heart disease: diagnosis, treatment, and gaps of knowledge	7
Cost-effectiveness of catheter-based radiofrequency renal denervation for the treatment of uncontrolled hypertension: an analysis for the UK based on recent clinical evidence	7
Assessing the health impact of low seafood omega-3 intake on ischaemic heart disease: trends, demographic disparities, and forecasts	7
T-TEER for Tricuspid Valve Regurgitation: A Sex-Based Real-World Analysis from the TRI-SPA Registry	7
Comprehensive risk factor management for hypertensive patients	7
Key priorities for the implementation of the 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes in low-resource settings	7
Remnant cholesterol and risk of premature mortality: an analysis from a nationwide prospective cohort study	7
Estimating the impact of implementing an integrated care management approach with Atrial fibrillation Better Care (ABC) pathway for patients with atrial fibrillation in England from 2020 to 2040	6
Impact of intravascular ultrasound for coronary bifurcations treated with last-generation stents: insights from the ULTRA-BIFURCAT registry	6
Relationship between hospital mortality and readmission rates after transcatheter aortic valve replacement	6
Existing heath disparities in congenital heart disease: the path forward to achieving health equity—A scientific statement of the European Association of Preventive Cardiology of the ESC	6
Association of atrial fibrillation with survival in patients with low-flow low-gradient aortic stenosis with preserved ejection fraction undergoing TAVI	6
Impact of the method of calculating 30-day readmission rate after hospitalization for heart failure. Data from the VancOuver CoastAL Acute Heart Failure (VOCAL-AHF) registry	6
Sex differences in the etiology and burden of heart failure across country income level: analysis of 204 countries and territories 1990–2019	6
A systematic assessment of the characteristics of randomized controlled trials cited by acute coronary syndrome clinical practice guidelines	6
Adapting predictive risk models and preventive strategies across different socio-economic regions to reduce global cardiovascular burden	6
Global, regional, and national burden of pulmonary arterial hypertension and related heart failure from 1990 to 2021, with predictions to 2050: insights from the global burden of disease study 2021	6
Safety and efficacy of direct oral anticoagulants in patients with anaemia and atrial fibrillation: an observational nationwide Danish cohort study	6
Machine learning-based identification of risk-factor signatures for undiagnosed atrial fibrillation in primary prevention and post-stroke in clinical practice	6
Association of socioeconomic status in the incidence, quality-of-care metrics, and outcomes for patients with cardiogenic shock in a pre-hospital setting	6
The burden of atrial fibrillation related to metabolic risks: different countries and territories, yet the same challenges	6
The patient journey in chronic coronary syndromes with/without obstructive coronary arteries	6
Mental health and anticoagulant prescription in atrial fibrillation	5
The Italian Fabry Disease Cardiovascular Registry (IFDCR)	5
Change in prevalence of ATTR variants in Italy: results from a national survey	5
Trends in ST-elevation myocardial infarction hospitalization among young adults: a binational analysis	5
Primary prevention ICD: essential safeguard or personalized selectivity?	5
Representativeness in randomised clinical trials supporting acute coronary syndrome guidelines	5
Catheter ablation as an adjunctive therapy to ICD implantation in Brugada Syndrome	5
Economic evaluation of the Liverpool heart failure virtual ward model	5
Meta-analysis of the Placebo and Nocebo effects associated with Placebo treatment in randomized trials of lipid-lowering therapies	5
Correction to: The evolving landscape of atrial fibrillation: diagnosis and therapy	5
Implications of structural right ventricular involvement in patients with hypertrophic cardiomyopathy	5
Aortic regurgitation management: a systematic review of clinical practice guidelines and recommendations	5
Cardiopulmonary long-term effects 30 months after severe COVID-19 infection	5
Driving restrictions following defibrillator implantation: a nationwide register-linked survey study on the impact on employment, daily living, and driving behaviour	5
Importance of diagnostic setting in determining mortality in patients with new-onset heart failure: temporal trends in Denmark from 1997 to 2017	5
Psoriasis and risk of new-onset degenerative valvular heart disease: a prospective cohort study	5
Global burden of heart failure in older adults: trends, socioeconomic inequalities, and future projections from 1990 to 2035	5
Correspondence to the European Heart Journal—Quality of Care and Clinical Outcomes in response to the paper by Thygesen et al. (2021)	5
Health economic evaluation of nation-wide screening programmes for atrial fibrillation in the Netherlands	5
New European Union law on medical devices: will it truly protect patients from malfunctioning cardiac implantable electronic devices?	5
Burden of cardiovascular disease among elderly: based on the Global Burden of Disease Study 2019	5
Cardiovascular outcomes and safety of semaglutide in non-overweight populations with type 2 diabetes: a comparison with dipeptidyl peptidase 4 inhibitors	5
Temporal trends in disease-specific causes of cardiovascular mortality amongst patients with cancer in the USA between 1999 and 2019	4
Correspondence to the European Heart Journal – Quality of Care and Clinical Outcomes in response to the paper by Warming et al. (2022): Atrial fibrillation and chronic obstructive pulmonary disease: d	4
De-frailing intervention for hospitalized cardiovascular patients in the TARGET-EFT randomized clinical trial	4
Inclusion and reporting by age, sex, and ethnicity in clinical studies of high-risk medical devices approved in the European Union	4
Trends in risk factors among young patients with acute myocardial infarction: a nationwide cohort study	4
Association of healthy sleep pattern with risk of recurrent cardiovascular events among patients with coronary heart disease	4
The first International Consortium for Health Outcomes Measurement (ICHOM) standard dataset for reporting outcomes in heart valve disease: moving from device- to patient- centered outcomes	4
Atrial fibrillation screening and clinical outcomes: a meta-analysis of randomized controlled trials	4
The impact of atrial fibrillation on prognosis in aortic stenosis	4
Editorial: Beyond obesity: metabolic status as key driver for cardiovascular outcomes in patients undergoing invasive coronary angiography	4
Management of mitral stenosis: a systematic review of clinical practice guidelines and recommendations	4
COP27 Climate Change Conference: urgent action needed for Africa and the world	4
Impact of the admitting ward on care quality and outcomes in non-ST-segment elevation myocardial infarction: insights from a national registry	4
Integrating Cultural Background into the Psychological and Social Prevention of Cardiovascular Diseases	4
Cardiovascular disease burden due to productivity losses in European Society of Cardiology countries	4
Feasibility of coronary access after transcatheter aortic valve implantation (TAVI): a systematic review and meta-analysis of observational studies	4

Comparison of mitral valve repair vs. replacement for mitral valve regurgitation	4
A hidden problem: peripheral artery disease in women	4
Long-term cardiovascular disease after pre-eclampsia: time to move from epidemiology to action	4
Heart failure clinical registries vs. registering the reality of heart failure	4
Incidence of myocardial infarction, heart failure, and cardiovascular mortality in patients with peripheral artery disease: trends between 1997 and 2016	4
Psychiatric morbidity and work participation in patients with congenital ventricular septal defects: a case-controlled study	4
Update on long-term cardiovascular risk after pre-eclampsia: a systematic review and meta-analysis	4
Transradial versus transfemoral approach for percutaneous coronary intervention in patients with ST-elevation myocardial infarction complicated by cardiogenic shock: a systematic review and meta-analy	4
Should we routinely measure patient quality of life after acute coronary syndrome?	4
Mechanical Circulatory Support Devices versus Standard Medical Therapy for Treatment of Myocardial Infarction Complicated by Cardiogenic Shock: a Network Meta-Analysis	4
The association of temporal sequence in atrial fibrillation and chronic obstructive pulmonary disease diagnosis and mortality risk: Reply	4
Bleeding risk using non-steroidal anti-inflammatory drugs in anticoagulated patients with atrial fibrillation: a nationwide cohort study	4
Stroke prevention with direct oral anticoagulants in high-risk elderly atrial fibrillation patients at increased bleeding risk	4
Atrial fibrillation—lost lifetimes and the urgent need for outcome-driven management	3
Assessment of the safety and efficacy of catheter ablation for atrial fibrillation in very elderly patients: insight from the national prospective registry study	3
Heart valve disease in the modern era: a call for holistic, long-term management	3
Prognostic value of weight loss in hospitalized patients with heart failure	3
A cost-effectiveness analysis of hypertrophic cardiomyopathy sudden cardiac death risk algorithms for implantable cardioverter defibrillator decision-making	3
Impact of glomerular filtration rate estimation formulas on MECKI score performance and prognostic accuracy in heart failure: the MECKI-RENAL study	3
Clinical and genetic diagnosis of familial hypercholesterolaemia in patients undergoing coronary angiography: the Ludwigshafen Risk and Cardiovascular Health Study	3
Acute coronary occlusion with vs. without ST elevation: impact on procedural outcomes and long-term all-cause mortality	3
Letter to the Editor in Response to Sengupta et al. (2022)	3
Corrigendum to: Cohort profile: Evaluation of the Methods and Management of Acute Coronary Events (EMMACE) longitudinal cohort	3
Association between cancer, CHA2DS2VASc risk, and in-hospital ischaemic stroke in patients hospitalized for atrial fibrillation	3
Transcatheter aortic valve implantation: the fountain of second youth?	3
Socioeconomic variations determine the clinical presentation, aetiology, and outcome of infective endocarditis: a prospective cohort study from the ESC-EORP EURO-ENDO (European Infective Endocarditis)	3
β-blocker adherence among patients with congenital long QT syndrome: a nationwide study	3
The controversy between atrial fibrillation subtypes and worsening heart failure	3
Withdrawn as duplicate: Quality of life and the assessment of surgical quality	3
Vaccines and myocardial injury in patients hospitalized for COVID-19 infection: the CardioCOVID-Gemelli study	3
An early accumulation of serum uric acid confers more risk of heart failure: a 10-year prospective cohort study	3
The evolving landscape of atrial fibrillation: diagnosis and therapy	3
Corrigendum to: Comparison of HAS-BLED and ORBIT bleeding risk scores in atrial fibrillation patients treated with non-vitamin K antagonist oral anticoagulants: a report from the ESC-EHRA EORP-AF Gene	3
Risk of incident cardiovascular disease among patients with gastrointestinal disorder: a prospective cohort study of 330 751 individuals	3
Data standards for atrial fibrillation/flutter and catheter ablation: the European Unified Registries for Heart Care Evaluation and Randomized Trials (EuroHeart)	3
Educational inequalities in cardiovascular diseases and their mediating factors across different generations: a prospective cohort study	3
Preparation for cardiac procedures: a cross-sectional study identifying gaps between outpatients’ views and experiences of patient-centred care	3
Predicting new-onset heart failure hospitalization of patients with atrial fibrillation: development and external validations of a risk score	3
Reduced access to primary care for immigrants increases cardiovascular complications and hospital admissions: the importance of information and education	3
Association of socioeconomic status with 30-day survival following out-of-hospital cardiac arrest in Scotland, 2011–2020	2
Adherence to perindopril/amlodipine/atorvastatin combination according to the administration strategy	2
Association of acute increases in serum creatinine with subsequent outcomes in patients with type 2 diabetes mellitus treated with sodium–glucose cotransporter 2 inhibitor or dipeptidyl peptidase-4 in	2
The quality of care and long-term mortality of out of hospital cardiac arrest survivors after acute myocardial infarction: a nationwide cohort study	2
WOMANOCA calls for better ANOCA care for all	2
Letter to the editor in response to Kobo et al. (2022)	2
Temporal trend analysis of rheumatic heart disease burden in high-income countries between 1990 and 2019	2
Corrigendum to: Sodium-glucose cotransporter 2 inhibitors in patients with heart failure: a systematic review and meta-analysis of randomized trials	2
High risk of rehospitalization within 1 year following a pulmonary embolism—insights from the Danish nationwide registries from 2000–2020	2
Uptitration of statin therapy in women and men: a population-based cohort study	2
Key priorities for the implementation of the 2023 ESC Guidelines for the management of endocarditis in low-resource settings	2
Aiming at a better guidance in the post-pulmonary embolism syndrome management: is the gap fully filled out?	2
Global, regional, and national burden of heart failure and its risk factors between 1990 and 2021 and projections to 2050: an analysis of the global burden of disease study	2
Specialist services for cardiomyopathy: quality care requires diagnostic accuracy	2
Effect of coronary artery bypass grafting on quality of life: a meta-analysis of randomized trials	2
Trends in treatment and outcomes of atrial fibrillation during 2007–17 in Finland	2
Sex differences in clinical profile, management, and outcomes of patients hospitalized for atrial fibrillation in the United States	2
Temporal trends of mortality in patients with infective endocarditis: a nationwide study	2
Sharing the load to improve clinical outcomes in cardiogenic shock treated using venoarterial ECMO	2
Relationship between remnant cholesterol and risk of heart failure in participants with diabetes mellitus: Reply	2
The cost-effectiveness of rivaroxaban with or without aspirin in the COMPASS trial	2
Kidney function and the comparative effectiveness and safety of direct oral anticoagulants vs. warfarin in adults with atrial fibrillation: a multicenter observational study	2
Quality counts: revisiting anticoagulation after mechanical aortic valve replacement in patients with atrial fibrillation	2
Impact of biomarker type on periprocedural myocardial infarction in patients undergoing elective PCI	2
Beyond obesity: metabolic status as a key driver for cardiovascular outcomes in patients undergoing invasive coronary angiography	2
The cardiovascular disease burden attributable to kidney dysfunction from 1990 to 2021: an age–period–cohort analysis of the Global Burden of Disease study	2
Effects of the COVID-19 pandemic on secondary care for cardiovascular disease in the UK: an electronic health record analysis across three countries	2
Impact of age on outcomes after transcatheter aortic valve implantation	2
Does Down syndrome influence the outcomes of congenital cardiac surgery? A systematic review and meta-analysis	2
Corrigendum to: Data standards for transcatheter aortic valve implantation: the European Unified Registries for Heart Care Evaluation and Randomised Trials (EuroHeart)	2
Need for home care or nursing home admission after myocardial infarction complicated by cardiogenic shock and/or out-of-hospital cardiac arrest	2
Longitudinal risk of death, hospitalizations for atrial fibrillation, and cardiovascular events following catheter ablation of atrial fibrillation: a cohort study	2
European Society of Cardiology quality indicators for the care and outcomes of adults undergoing transcatheter aortic valve implantation	2
Clinicoeconomic burden among heart failure patients with severely reduced ejection fraction after hospital admission: HF-RESTORE	2
The European Heart Journal. Quality of Care and Clinical Outcome in the years to come: a salutation from the incoming Editor-in-Chief	2
Cost-effectiveness of intravascular ultrasound-guided percutaneous intervention in patients with acute coronary syndromes: a UK perspective	2